Simvastatin has beneficial effect on pulmonary artery hypertension by inhibiting NF-κB expression

Molecular and Cellular Biochemistry

Volumn 354, Issue 1-2, 2011, Pages 77-82

  Liu, Zhong Qiang ^a   Liu, Bing ^b   Yu, Li ^a   Wang, Xiao Qing ^a   Wang, Juan ^a   Liu, Han Min ^a  

^a SICHUAN UNIVERSITY   (China)

^b Luzhou Medical University   (China)

Author keywords

Expression; Nuclear factor kappa B; Pulmonary hypertension; Simvastatin

Indexed keywords

ANTIHYPERTENSIVE AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PARTHENOLIDE; PLATELET DERIVED GROWTH FACTOR; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ARTERY PRESSURE; LUNG PARENCHYMA; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; WESTERN BLOTTING;

ANIMALS; ARTERIOLES; BLOOD PRESSURE; CELL PROLIFERATION; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; HYPERTENSION, PULMONARY; LUNG; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PNEUMONECTOMY; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 79959776473     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0807-4     Document Type: Article

References (15)

1. Stringham R, Shah NR (2010) Pulmonary arterial hypertension: an update on diagnosis and treatment. Am Fam Physician 82(4):370-377
2. Jeffery TK, Wanstall JC (2001) Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92(1):1-20 (Pubitemid 34032020)
3. McKinsey TA, Zhang CL, Olson EN (2002) MEF-2: a calcium dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27:40-47 (Pubitemid 34131624)
4. Sen R, Baltimore D (1986) Inducibility of the immunoglobulin enhancer-binding protein NF-κB by a post translational mechanism. Cell 47:921-928 (Pubitemid 17005065)
5. Cheng DY, Guan J, Xia XQ et al (2006) The change of nuclear factor-kappa B expression in the lung tissues of chromic hypoxic rats. Bull Sichuan University Med Sect 4:611-613 (Pubitemid 44155450)
6. Stroes E (2005) Statins and LDL-cholesterol lowering: an overview. Curr Med Res 6:9-16
7. Okada K, Tanaka Y, Bernstein M et al (1997) Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 151:1019-1025 (Pubitemid 27424311)
8. Girgis RE, Mozammel S, Champion HC (2007) Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol 292:1105-1110
9. Jiang BH, Tawara S, Abe K (2007) Acute vasodilatou effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 49:85-89
10. Reynolds AM, Xia W, Holmes MD (2007) Bone morphogenetic protein type 2 receptor (BMPR2) gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physilo 292:1182-1192
11. Fouty BW, Rodman MD (2003) Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway. Circ Res 92:501-509 (Pubitemid 36368662)
12. Newman JH, Fanburg BL, Archer SL (2004) Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Circulation 109(24):2947-2952
13. Nishimura T, Vaszar LT, Faul JL (2003) Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 108:1640-1645 (Pubitemid 37187793)
14. Yukiyo O, Masafumi T, Koichi T (2002) Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol 40:907-915
15. Ahn KS, Sethi G, Aggarwal BB (2007) Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappa B-dependent antiapoptotic gene products: role of I kappa B alpha kinase and TGF-beta-activated kinase-1. J Immunol 178(4):2507-2516 (Pubitemid 46233452)